Hong Kong, China

Guan Yang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: City University of Hong Kong. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guan Yang. Retrieved from https://idiyas.com/inventor/guan-yang-64icsk06

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Guan Yang in Treating Hypervirulent Infections

Introduction

Guan Yang is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of medicine, particularly in the treatment of hypervirulent infections. His innovative approach combines the use of antibiotics with non-steroidal anti-inflammatory drugs or specific inhibitors to enhance treatment efficacy.

Latest Patents

Guan Yang holds 1 patent for his work titled "Methods for treating hypervirulent infection." This patent outlines a method for treating hypervirulent Klebsiella pneumoniae (hvKp) infections in subjects. The method involves co-administering a therapeutically effective amount of an antibiotic alongside a non-steroidal anti-inflammatory drug or a signal transducer and activator of transcription 1 inhibitor.

Career Highlights

Guan Yang is affiliated with the City University of Hong Kong, where he conducts research and develops innovative medical solutions. His work has garnered attention for its potential to improve patient outcomes in the face of challenging infections.

Collaborations

Guan Yang collaborates with esteemed colleagues, including Sheng Chen and Qi Xu. Their combined expertise contributes to advancing research in the field of infectious diseases.

Conclusion

Guan Yang's innovative methods for treating hypervirulent infections represent a significant advancement in medical science. His contributions are poised to make a lasting impact on the treatment of complex infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…